{"id":"NCT00385008","sponsor":"GlaxoSmithKline","briefTitle":"TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine","officialTitle":"An Open Label, Single Dose, Parallel Group Study to Evaluate Absorption and Transit Characteristics of TREXIMA and RELPAX in Patients Inside and Outside of an Acute Migraine Attack.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-09-13","primaryCompletion":"2006-11-24","completion":"2006-11-24","firstPosted":"2006-10-06","resultsPosted":"2018-02-12","lastUpdate":"2018-02-12"},"enrollment":20,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Migraine Disorders"],"interventions":[{"type":"DRUG","name":"Combination Product (sumatriptan succinate / naproxen sodium)","otherNames":[]},{"type":"DRUG","name":"RELPAX(eletriptan) 40mg Tablet","otherNames":["Combination Product (sumatriptan succinate / naproxen sodium)"]}],"arms":[{"label":"Arm 1","type":"OTHER"},{"label":"Arm 2","type":"OTHER"}],"summary":"An evaluation of tablet disintegration and absorption and gastric transit of sumatriptan and naproxen sodium from a TREXIMA tablet and eletriptan from a RELPAX 40mg tablet.","primaryOutcome":{"measure":"Time to 10%, 50%, 90% and Complete Gastric Empting of the Radioactive Markers Representing Sumatriptan, Naproxen and Eletriptan","timeFrame":"Day 1 of each treatment administration (For 30 days)","effectByArm":[{"arm":"TREXIMA (Sumatriptan 85 mg + Naproxen 500 mg)","deltaMin":0.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":10},"commonTop":["Joint stiffness","Muscle tightness","Paraesthesia","Musculoskeletal pain","Diarrhoea"]}}